📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
Latest filing: 2026-08-26 19:44
12 analysed today
12
Today
133,654
All-time analysed
40,136
Positive
6,284
Negative
79,412
Neutral
7,754
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
24 announcements match the current filters (relevance ≥ 5).
Mold-Tek Packaging approves 1:1 bonus issue, ₹3 final dividend, and appoints Whole-Time Director
Mold-Tek Packaging's Board has approved a 1:1 bonus issue, issuing 3,32,28,914 equity shares of ₹5 each by capitalizing ₹16.61 Cr from its ₹655.12 Cr free reserves. The Board also recommended a final dividend of ₹3 per share (60%) for FY26 and proposed doubling the authorized share capital from ₹20 Cr to ₹40 Cr. In addition, Mr. Rana Pratap Janumahanti (son of CMD) was appointed as Whole-Time Director (Director - Marketing & Strategy) for a 5-year term effective October 1, 2026.
Confidence: HIGH
What changedApproved a 1:1 bonus share issue, recommended a ₹3/share final dividend, increased authorized capital to ₹40 Cr, and appointed a new Whole-Time Director.
Why it mattersThe bonus issue expands trading liquidity and signals management confidence supported by ₹655.12 Cr in reserves, while management changes formalize succession in core growth verticals like Pharma and FMCG.
Bonus Ratio: 1:1Final Dividend: ₹3 per share (60%)Bonus Capitalization Amount: ₹16.61 CrAvailable Free Reserves: ₹655.12 CrPost-Bonus Share Count: 6,64,57,828 shares
📅 Short termPositive sentiment expected around the 1:1 bonus issue and ₹3/share dividend announcement leading up to the AGM on September 21, 2026.
📈 Long termIndicates steady capital return capability and strengthens governance and leadership for ongoing expansions in Pharma and Northern India operations.
⚠ Risk flags
- Related-party appointment (appointment of CMD's son to the Board)
- Subject to shareholder approval at the upcoming AGM
Key Highlights
Approved 1:1 bonus share issue, capitalizing ₹16.61 Cr out of ₹655.12 Cr available free reserves
Recommended final dividend of ₹3 per equity share (60% on ₹5 face value) for FY25-26
Authorized share capital increased from ₹20.00 Cr (4.00 Cr shares) to ₹40.00 Cr (8.00 Cr shares)
Appointed Mr. Rana Pratap Janumahanti as Director - Marketing & Strategy for 5 years w.e.f. October 1, 2026
👀 What to Watch
Track shareholder approval at the AGM scheduled for September 21, 2026, and the upcoming announcement of record dates for the 1:1 bonus issue and dividend payout.
Mold-Tek Packaging Board Approves 1:1 Bonus Issue and Recommends ₹3/Share Final Dividend
Mold-Tek Packaging's Board has approved a 1:1 bonus share issue, issuing 3,32,28,914 equity shares by capitalizing ₹16.61 Cr from free reserves (which stand at ₹655.12 Cr as of March 31, 2026). The Board also recommended a final dividend of ₹3 per share (60% of face value ₹5) for FY26, subject to shareholder approval. Additionally, the company increased its authorized share capital from ₹20 Cr to ₹40 Cr and appointed Mr. Rana Pratap Janumahanti as Director - Marketing and Strategy (Whole-Time Director).
Confidence: HIGH
What changedThe company announced a 1:1 bonus issue, a ₹3 per share final dividend, raised its authorized share capital to ₹40 Cr, and inducted top management to the Board.
Why it mattersThe bonus issue improves stock liquidity and capital base with minimal reserve depletion (₹16.61 Cr out of ₹655.12 Cr), while the ₹3 dividend signals healthy ongoing cash returns.
Bonus Ratio: 1:1Final Dividend: ₹3 per share (60%)Bonus Capitalization Amount: ₹16.61 CrFree Reserves Available (March 31, 2026): ₹655.12 CrPost-Bonus Paid-up Capital: ₹33.23 Cr
📅 Short termPositive sentiment driven by the corporate actions (1:1 bonus and ₹3 dividend) ahead of the AGM on September 21, 2026.
📈 Long termEnhances equity liquidity and reflects management confidence; operational focus remains on pharma and Food & FMCG packaging ramp-ups.
⚠ Risk flags
- Promoter-family succession/induction (Mr. Rana Pratap Janumahanti is the CMD's son, subject to shareholder approval)
Key Highlights
Approved 1:1 bonus issue of 3,32,28,914 equity shares of ₹5 each, doubling paid-up equity capital to ₹33.23 Cr
Capitalization of ₹16.61 Cr against available audited free reserves/retained earnings of ₹655.12 Cr as of March 31, 2026
Recommended FY26 final dividend of ₹3 per share (60% on ₹5 face value)
Increased authorized share capital from ₹20.00 Cr to ₹40.00 Cr
Convening 29th Annual General Meeting on September 21, 2026, to seek shareholder approvals
👀 What to Watch
Track the upcoming AGM on September 21, 2026, for shareholder approval, followed by the declaration of the record date for both the 1:1 bonus issue and the ₹3/share dividend payout.
Mold-Tek Packaging Approves 1:1 Bonus Issue, ₹3 Final Dividend & Board Appointments
Mold-Tek Packaging's Board has approved a 1:1 bonus equity share issue, utilizing ₹16.61 crore from its free reserves pool of ₹655.12 crore. The Board also recommended a final dividend of ₹3 per share (60% on ₹5 face value) for FY26, alongside an increase in authorized share capital to ₹40 crore. Additionally, Mr. Rana Pratap Janumahanti was appointed as Whole-Time Director (Marketing and Strategy) for 5 years effective October 1, 2026. All corporate actions are subject to shareholder approval at the AGM scheduled for September 21, 2026.
Confidence: HIGH
What changedThe company announced a 1:1 bonus share issue, a ₹3/share dividend payout, doubled its authorized share capital, and elevated executive leadership.
Why it mattersThe 1:1 bonus expands liquidity by doubling the paid-up equity base to ₹33.23 crore, while the ₹3 dividend rewards shareholders backed by strong free reserves of ₹655.12 crore.
Bonus Ratio: 1:1Final Dividend: ₹ 3/- per shareBonus Capitalization Amount: ₹ 16,61,44,570Free Reserves as of Mar 31, 2026: ₹ 655,11,90,319Post-Bonus Paid-up Capital: ₹ 33,22,89,140AGM Date: September 21, 2026
📅 Short termMarket sentiment should be supported by the 1:1 bonus issue and ₹3 dividend recommendation as investors await record date disclosures.
📈 Long termLimited operational impact; the corporate actions improve stock liquidity and signal leadership succession as the company expands into high-margin Pharma and FMCG packaging.
Key Highlights
Recommended 1:1 bonus issue (1 equity share for every 1 share held), issuing 3.32 crore shares worth ₹16.61 crore
Declared final dividend of ₹3 per share (60% on face value of ₹5) for FY26
Free reserves available for capitalization stood at ₹655.12 crore as of March 31, 2026
Increased authorized share capital from ₹20.00 crore to ₹40.00 crore
Appointed Mr. Rana Pratap Janumahanti as Whole-Time Director for a 5-year term from October 1, 2026
👀 What to Watch
Track the upcoming AGM on September 21, 2026, for shareholder approval and subsequent announcements of record dates for bonus entitlement and dividend distribution.
Mold-Tek Packaging recommends 1:1 bonus issue, doubling paid-up equity share capital
Mold-Tek Packaging Limited's Board of Directors has recommended a bonus issue of equity shares in the ratio of 1:1 (one bonus share for every one existing share held), subject to shareholder approval. The issuance will increase the company's paid-up equity share capital from ₹16.61 crore to ₹33.23 crore, comprising 6,64,57,828 equity shares of ₹5 face value each. The capitalization will be drawn from the company's reserves and surplus, which stood at ₹655 crore as of March 31, 2026. Additionally, the Board proposed the appointment of Mr. Janumahanti Rana Pratap as Director - Marketing and Strategy.
Confidence: HIGH
What changedThe Board recommended a 1:1 bonus share issue and proposed appointing Mr. Janumahanti Rana Pratap to the Board.
Why it mattersThe bonus issue increases floating liquidity and share accessibility for retail investors without altering underlying net worth or business fundamentals.
Bonus ratio: 1:1Existing paid-up equity capital: ₹ 16,61,44,570/-Post-bonus paid-up equity capital: ₹ 33,22,89,140/-Reserves & Surplus (March 31, 2026): ₹ 655 crores
📅 Short termTrading liquidity may increase ahead of and following the ex-bonus date once the record date is announced.
📈 Long termLimited operational impact as it is an accounting capitalization of existing reserves; reflects structured leadership transition.
Key Highlights
Recommended 1:1 bonus share issue (1 new share for every 1 existing fully paid-up share)
Paid-up equity share capital to double from ₹16,61,44,570 to ₹33,22,89,140 (6,64,57,828 shares of ₹5 each)
Company reserves and surplus stood at ₹655 crore as of March 31, 2026
Board proposed the appointment of Mr. Janumahanti Rana Pratap (14 years with company) as Director - Marketing and Strategy
👀 What to Watch
Track the upcoming shareholder voting outcome for approval of the bonus issue and the subsequent intimation of the record date.
Mold-Tek Packaging Declares 1:1 Bonus Issue and ₹3/Share Final Dividend
Mold-Tek Packaging's Board has approved a 1:1 bonus issue (1 bonus equity share of ₹5 for every 1 share held) and recommended a final dividend of ₹3 per share (60%) for FY26. The bonus issue involves capitalizing ₹16.61 Cr from the company's free reserves of ₹655.12 Cr as of March 31, 2026, doubling the paid-up equity base to 6.65 crore shares. Additionally, the Board approved the appointment of Mr. Rana Pratap Janumahanti as Whole Time Director (Director - Marketing and Strategy) for a 5-year term starting October 1, 2026.
Confidence: HIGH
What changedThe Board recommended a 1:1 bonus issue, a ₹3 per share final dividend, raised authorized share capital to ₹40 Cr, and appointed a new Whole Time Director.
Why it mattersThe 1:1 bonus issue improves share liquidity and expands the equity base using just ~2.5% of reserves, while the ₹3 dividend rewards shareholders without straining the balance sheet.
Bonus Ratio: 1:1Final Dividend per share: ₹ 3/-Bonus Capitalization Amount: ₹ 16,61,44,570/-Free Reserves Available: ₹ 655,11,90,319Post-Bonus Share Capital: ₹ 33,22,89,140/-AGM Date: September 21, 2026
📅 Short termPositive sentiment driven by the corporate actions (1:1 bonus issue and dividend payout) ahead of the AGM on September 21, 2026.
📈 Long termLimited direct financial impact from the bonus share accounting adjustment, but leadership elevation of the next-generation promoter aligns with long-term succession and expansion in Pharma/FMCG packaging.
⚠ Risk flags
- Shareholder approval pending at AGM
Key Highlights
Approved 1:1 bonus share issue, issuing 3,32,28,914 equity shares of ₹5 each
Recommended final dividend of ₹3 per share (60% of face value) for FY26
Utilizing ₹16.61 Cr from free reserves/retained earnings totaling ₹655.12 Cr
Authorized share capital increased from ₹20 Cr to ₹40 Cr
Appointed Mr. Rana Pratap Janumahanti as Whole Time Director w.e.f. October 1, 2026
👀 What to Watch
Track shareholder approval at the upcoming AGM on September 21, 2026, and the subsequent announcement of record dates for both the 1:1 bonus issue and the ₹3/share final dividend.
Mold-Tek Packaging Approves 1:1 Bonus Issue, ₹3 Final Dividend, and Increases Authorized Capital
Mold-Tek Packaging's Board has approved a 1:1 bonus share issue (1 equity share for every 1 share held), capitalizing ₹16.61 crore from its free reserves of ₹655.12 crore. The Board also recommended a final dividend of ₹3 per share (60% on face value of ₹5) for FY26. To accommodate the bonus issue, the authorized share capital is being doubled from ₹20 crore to ₹40 crore, alongside the appointment of Rana Pratap Janumahanti as Whole Time Director.
Confidence: HIGH
What changedThe Board approved a 1:1 bonus issue, a ₹3/share dividend, doubled the authorized capital to ₹40 crore, and inducted Rana Pratap Janumahanti as Whole Time Director.
Why it mattersThe bonus issue expands the paid-up equity base to 6.65 crore shares (₹33.23 crore), enhancing market liquidity, while utilizing a fraction (~2.5%) of the company's robust ₹655.12 crore free reserves.
Bonus Ratio: 1:1Bonus Capitalization Amount: ₹16.61 CrFree Reserves Available: ₹655.12 CrFinal Dividend per Share: ₹3.00 (60%)Post-Bonus Paid-up Capital: ₹33.23 Cr
📅 Short termPositive sentiment driven by the 1:1 bonus issue and ₹3 dividend announcement, with trading interest expected around record date announcements.
📈 Long termEnhances equity liquidity in the secondary market; core business performance remains tied to capacity utilization across the Panipat and Sultanpur facilities.
Key Highlights
Approved 1:1 bonus issue of 3,32,28,914 equity shares of ₹5 each, totaling ₹16.61 crore
Bonus shares to be capitalized from free reserves/retained earnings balance of ₹655.12 crore as of March 31, 2026
Recommended final dividend of ₹3 per equity share (60% on ₹5 face value) for FY26
Authorized share capital increased from ₹20 crore (4 crore shares) to ₹40 crore (8 crore shares)
Appointed Rana Pratap Janumahanti as Director - Marketing and Strategy (Whole Time Director) for 5 years effective October 1, 2026
👀 What to Watch
Track the upcoming AGM on September 21, 2026 for shareholder approval and subsequent intimation of the record dates for both the bonus issue and final dividend payout.
Mold-Tek Packaging Approves 1:1 Bonus Issue and Recommends ₹3/Share Final Dividend
Mold-Tek Packaging's Board has approved a 1:1 bonus issue (1 equity share of ₹5 for every 1 share held), issuing 3,32,28,914 shares by capitalizing ₹16.61 crore from available free reserves of ₹655.12 crore. The Board also recommended a final dividend of ₹3 per share (60% on FV of ₹5) for FY26. To accommodate the bonus issue, the authorized share capital is being doubled from ₹20 crore to ₹40 crore, subject to shareholder approval at the AGM on September 21, 2026.
Confidence: HIGH
What changedThe Board approved a 1:1 bonus equity issue, a ₹3/share final dividend, an increase in authorized capital to ₹40 crore, and appointed Mr. Rana Pratap Janumahanti as Whole-Time Director.
Why it mattersThe 1:1 bonus doubles the paid-up share count to 6.65 crore shares to improve trading liquidity without altering underlying business fundamentals or cash reserves significantly.
Bonus Ratio: 1:1Bonus Shares to Issue: 3,32,28,914Free Reserves Capitalized: ₹16.61 CrAvailable Free Reserves: ₹655.12 CrFinal Dividend: ₹3 per share (60%)Post-Bonus Paid-up Capital: ₹33.23 Cr
📅 Short termLikely positive market sentiment around the 1:1 bonus announcement and dividend reward; stock will adjust ex-bonus around the eventual record date.
📈 Long termLimited operational impact; the bonus restructuring enhances stock liquidity while the dividend reflects ongoing cash generation.
⚠ Risk flags
- Subject to shareholder approval at the upcoming AGM on September 21, 2026
Key Highlights
Approved 1:1 bonus share issue (1 share of ₹5 for every 1 share held)
Capitalization of ₹16.61 Cr from free reserves/retained earnings (₹655.12 Cr available as of March 31, 2026)
Recommended FY26 final dividend of ₹3 per equity share (60% of FV ₹5)
Doubled authorized share capital from ₹20 Cr (4 Cr shares) to ₹40 Cr (8 Cr shares)
Bonus shares estimated to be credited/dispatched within 2 months of board approval
👀 What to Watch
Track voting outcomes at the 29th AGM scheduled for September 21, 2026, and watch for subsequent intimations regarding the record dates for dividend and bonus entitlements.
Rs 300 Cr+ Quarterly Revenue; EBITDA/kg Hits Record Rs 46.7 in Q1 FY27
Mold-Tek Packaging reported a record quarterly turnover exceeding Rs 300 Cr, driven by high-margin segments and raw material price pass-throughs. EBITDA per kg reached a historical high of Rs 46.7, significantly above the typical Rs 40-42 range, aided by the consolidation of Hyderabad manufacturing units from five to two. While volume growth was tempered at 6% due to a 17% decline in the lubricant segment caused by base oil supply issues, the Pharma and Food/FMCG segments showed strong momentum. Management expects to sustain an EBITDA per kg of Rs 44-45 for the full year FY27.
Confidence: HIGH
What changedThe company successfully consolidated five Hyderabad units into two and shifted its product mix toward higher-margin Pharma and Food/FMCG packaging.
Why it mattersThe record EBITDA per kg demonstrates structural margin improvement and the ability to pass through volatile raw material costs to customers.
Q1 Revenue: Rs 300 Cr+EBITDA per kg: Rs 46.7Lube Segment Volume Growth: -17%Q1 Capex: Rs 20-22 CrWorking Capital: Rs 125 CrPharma Sales Growth: 38%
📅 Short termThe record margin performance and revenue milestone are likely to be viewed positively by the market in the coming weeks.
📈 Long termThe company is structurally diversifying away from decorative paints (aiming for 40% share in 3-4 years) toward high-growth Pharma and FMCG segments.
⚠ Risk flags
- Raw material price volatility
- Geopolitical risks affecting base oil supply for the lube segment
- High client concentration (top 10 customers = 60-70% revenue)
Key Highlights
Quarterly turnover crossed the Rs 300 Cr mark for the first time in the company's history.
EBITDA per kg reached a record Rs 46.7, up from the historical average of Rs 40-42.
Lube segment volumes declined by 17% due to base oil unavailability for private players amid geopolitical tensions.
Pharma segment sales grew 38% YoY, now contributing 3.5% to total sales value.
Invested Rs 20-22 Cr in capital expenditure during Q1 FY27.
👀 What to Watch
Watch for the volume ramp-up in the Food & FMCG segment and the sustainability of the Rs 45/kg EBITDA margin as raw material prices (PP copolymer) stabilize from recent peaks.
25% Revenue Growth in Q1 FY27; Pharma Segment Volume Surges 39%
Mold-Tek Packaging reported a strong Q1 FY27 with revenue reaching ₹300.45 Cr, a 24.9% YoY increase. While total sales volume grew by a modest 6.25% to 12,089 MT, the company achieved a significant 12% improvement in EBITDA per kg to ₹46.68. This was driven by a strategic shift toward high-margin segments, with Pharma volumes growing 39% and Food/FMCG volumes growing 26% YoY. PAT increased 14.19% to ₹25.57 Cr, despite a 92 bps contraction in EBITDA margins due to higher material costs.
Confidence: HIGH
What changedThe company has successfully shifted its product mix toward higher-margin Pharma and Food packaging while consolidating its manufacturing footprint in Hyderabad for better cost control.
Why it mattersThe improvement in EBITDA per kg (₹46.68 vs ₹41.64) demonstrates pricing power and the success of premium In-Mold Labelling (IML) products, which helps insulate the company from volume volatility in traditional segments like Lubricants.
Revenue (Q1 FY27): ₹300.45 CrRevenue vs TTM Revenue: 40.6%EBITDA per KG: ₹46.68Pharma Volume Growth: 39%PAT (Q1 FY27): ₹25.57 CrInstalled Capacity: 66,900 TPA
📅 Short termThe stock is likely to react positively to the strong double-digit revenue and PAT growth, alongside the significant jump in high-margin Pharma volumes.
📈 Long termStructural expansion into Pharma and Food/FMCG packaging, combined with a capacity increase to nearly 67,000 TPA, positions the company for sustained earnings growth beyond its traditional paint and lubricant base.
⚠ Risk flags
🔬 Flagged for deeper Multibagger analysis — view briefs →
- High customer concentration (top 10 clients account for 60-70% of revenue)
- Raw material cost volatility (material costs rose 32% YoY)
- 17% volume decline in the Lubricants segment
Key Highlights
Revenue grew 24.9% YoY to ₹300.45 Cr, representing ~40.6% of the previous TTM revenue.
Pharma segment volume increased by 39% YoY to 263 MT, continuing its high-growth momentum.
EBITDA per KG improved by 12% to ₹46.68, reflecting better product mix and operational efficiency.
Consolidated 5 manufacturing units in Hyderabad into 2 locations to unlock EBITDA expansion.
Total sales volume reached 12,089 MT, up from 11,378 MT in the previous year's quarter.
👀 What to Watch
Monitor the capacity utilization at the new Panipat and Sultanpur (Pharma) units, as these are critical for maintaining the current high-margin growth trajectory. Watch for the impact of raw material price pass-through lags on margins in upcoming quarters.
Q1 Revenue crosses ₹300 Cr; EBITDA per kg hits record ₹46.68
Mold-Tek Packaging reported a strong Q1 FY27 with net sales growing 24.9% YoY to ₹300.45 cr, surpassing the ₹300 cr quarterly milestone. Profitability reached new heights with EBITDA per kg hitting a record ₹46.68, driven by a 38.75% volume surge in the high-margin Pharma segment. Despite geopolitical headwinds affecting the Lube segment, the company achieved 75% capacity utilization following the consolidation of five Hyderabad units into two. Net profit grew 14.15% YoY to ₹25.57 cr, supported by robust demand in Food & FMCG (+26.2% volume growth).
Confidence: HIGH
What changedQuarterly revenue crossed the ₹300 cr mark for the first time, and the company achieved record-high operational efficiency (EBITDA/kg) through unit consolidation and product mix optimization.
Why it mattersThe successful scaling of the Pharma and Food/FMCG segments is reducing the company's reliance on the cyclical Paint and Lube sectors, structurally improving margin profiles and asset utilization.
Q1 Net Sales: ₹300.45 crQ1 vs TTM Revenue: 40.6%EBITDA per kg: ₹46.68Pharma Volume Growth: 38.75%Capacity Utilization: 75%Installed Capacity: 63,000 TPA
📅 Short termThe stock is likely to react positively to the record EBITDA margins and the strong volume growth in high-margin segments despite geopolitical pressures.
📈 Long termThe transition from a commodity-linked packaging player to a specialized Pharma and FMCG packaging provider, backed by in-house robotics and IML technology, supports a long-term margin expansion thesis.
⚠ Risk flags
🔬 Flagged for deeper Multibagger analysis — view briefs →
- Geopolitical risks impacting Lube segment demand
- High customer concentration (top 10 clients = 60-70% revenue)
- Raw material price volatility pass-through lag
Key Highlights
Net Sales increased 24.90% YoY to ₹300.45 cr, representing ~40.6% of the previous TTM revenue.
EBITDA per kg reached a historical high of ₹46.68, up from ₹41.64 in Q1 FY26.
Pharma segment volume grew by 38.75% YoY, with plans to expand into Ophthalmic-Packs and medical devices.
Consolidated 5 Hyderabad units into 2 major units (Annaram and Sultanpur) to reduce overheads and rejections.
Food & FMCG segment volume grew 26.20% YoY, supported by doubling production at the Panipat facility.
👀 What to Watch
Monitor the ramp-up of the Panipat facility and the execution of the entry into Ophthalmic-Packs and medical devices. Investors should also track if the record EBITDA margins are sustainable given the 1-3 month lag in passing through raw material cost changes.
Rs 300.45 Cr Revenue in Q1 FY27; EBITDA per kg hits record Rs 46.68
Mold-Tek Packaging reported a strong Q1 FY27 with revenue crossing the Rs 300 Cr milestone for the first time, a 24.9% YoY increase. Net profit grew 14.15% to Rs 25.57 Cr, supported by a record EBITDA of Rs 46.68 per kg, driven by operational consolidation and 75% capacity utilization. The high-margin Pharma segment showed robust volume growth of 38.75% YoY, while the company added several new clients in the Food and Pharma sectors. This quarterly revenue represents approximately 40.6% of the previous TTM revenue, indicating a significant scale-up in operations.
Confidence: HIGH
What changedThe company achieved record quarterly revenue and profitability margins (EBITDA/kg) through segment diversification and capacity expansion.
Why it mattersThe shift towards high-margin Pharma and Food/FMCG packaging reduces reliance on the cyclical paint and lubricant sectors, structurally improving the company's margin profile.
Revenue (Q1 FY27): Rs 300.45 CrPAT (Q1 FY27): Rs 25.57 CrEBITDA per kg: Rs 46.68Pharma Volume Growth: 38.75%Q1 Revenue vs TTM Revenue: 40.6%Installed Capacity: 63,000 TPA
📅 Short termThe stock is likely to react positively to the record EBITDA margins and the milestone of crossing Rs 300 Cr in quarterly revenue.
📈 Long termThe ongoing expansion into high-value pharmaceutical packaging and electronics/semiconductor packaging could lead to a structural re-rating if execution remains consistent.
⚠ Risk flags
🔬 Flagged for deeper Multibagger analysis — view briefs →
- High customer concentration (top 10 clients account for 60-70% of revenue)
- Raw material price volatility pass-through lag (1-3 months)
Key Highlights
Quarterly revenue crossed Rs 300 Cr for the first time, reaching Rs 300.45 Cr (up 24.9% YoY).
EBITDA per kg reached a historical high of Rs 46.68 due to improved capacity utilization.
Pharma segment volume grew by 38.75% YoY, with plans to enter Ophthalmic-Packs and medical devices.
Total sales volume increased 6.25% YoY to 12,089 MT.
Installed injection molding capacity expanded to over 63,000 TPA from 46,000 TPA in FY23.
👀 What to Watch
Monitor the ramp-up of the Panipat facility and the execution timeline for the new Ophthalmic-Packs and medical device verticals, which are expected to be high-margin drivers.
Mold-Tek Packaging Q4 FY26: Pharma Segment Surges 200% as Full-Year Sales Grow 13.4%
Mold-Tek Packaging reported a healthy 13.4% sales growth for FY26, driven by a massive 200% surge in the Pharma packaging segment which reached ₹34.4 crores. The company is pivoting towards high-margin segments, with Pharma targets set at ₹50-₹55 crores for FY27 and a planned reduction in capex to ₹80-₹85 crores. While the Lubricants segment saw a decline due to the loss of the BPCL contract, strong recoveries in Paints and Food/FMCG offset the impact. Management expects capacity to reach nearly 70,000 MTPA by FY27, focusing on brownfield expansions to improve utilization and margins.
Key Highlights
Pharma packaging segment grew by over 200% in FY26, contributing ₹34.4 crores to total revenue.
Overall sales growth stood at 13.4% for the year, supported by a 17% Q4 growth in the Asian Paints account.
Planned capex for FY27 reduced to ₹80-₹85 crores from ₹120 crores, focusing on brownfield expansion.
Capacity utilization currently stands at approximately 68% with 43,000 tons utilized out of 63,000 MTPA.
Grasim (Aditya Birla Group) volumes grew 60% YoY, becoming a top 10 customer for the company.
👀 What to Watch
Investors should favor the stock's shift toward high-margin Pharma and FMCG segments which are de-risking the portfolio from the volatile Lubricants business. Monitor the execution of brownfield expansions at Mysore and Satara for margin expansion.
Mold-Tek Packaging FY26 PAT Rises 20.35% to ₹72.87 Cr; EBITDA Up 20.59%
Mold-Tek Packaging Limited reported a robust financial performance for the fiscal year ended March 31, 2026, with a 20.35% increase in Profit After Tax (PAT) to ₹72.87 crore. Annual revenue grew by 13.48% to ₹886.61 crore, supported by an 11.39% growth in sales volumes across key segments. The company demonstrated strong operational efficiency, with EBITDA growing by 20.59% year-on-year. For the fourth quarter alone, PAT surged by approximately 26.8% compared to the same period last year, indicating accelerating momentum.
Key Highlights
Annual Revenue increased by 13.48% YoY to ₹886.61 crore in FY26.
Net Profit (PAT) for the full year rose by 20.35% to ₹72.87 crore from ₹60.55 crore.
Sales volumes grew by 11.39% driven by strong demand across key business segments.
EBITDA growth of 20.59% reflects significant improvement in operational performance.
Q4 FY26 Revenue stood at ₹237.86 crore, representing a 17.4% increase over Q4 FY25.
👀 What to Watch
The strong double-digit growth in both revenue and profitability suggests healthy demand and operational efficiency. Investors may consider this a positive signal for long-term growth in the rigid packaging sector.
Mold-Tek Packaging Reports Strong FY26 Performance with 20% PAT Growth to ₹72.87 Cr
Mold-Tek Packaging delivered a robust financial performance for FY26, with revenue growing 13.48% to ₹886.60 crore and PAT increasing 20.35% to ₹72.87 crore. The company achieved significant margin improvement, with EBITDA per KG rising 8% to ₹40.74, driven by plant consolidation and a shift towards high-margin segments like Pharma and Food & FMCG. The Pharma segment was a standout performer, recording 220% growth during the year. Operational efficiency was further bolstered by backward integration in label making and the implementation of AI-based inspection systems.
Key Highlights
FY26 Revenue grew 13.48% YoY to ₹886.60 crore, while Q4 revenue rose 17.40% to ₹237.86 crore.
Annual PAT increased by 20.35% to ₹72.87 crore, with Q4 PAT showing a stronger growth of 26.88% YoY.
EBITDA per KG improved from ₹37.60 to ₹40.74, reflecting better product mix and cost controls.
The Pharma segment achieved 220% growth in FY26, while the Food & FMCG segment grew by 15%.
Total sales volume for the full year reached 42,628 MT, marking an 11.41% increase over the previous year.
👀 What to Watch
Investors should note the successful margin expansion and the rapid growth in high-value segments like Pharma and Food. The company's focus on innovation, such as AI-based automation and new IP-based caps, positions it well for continued premiumization.
Mold-Tek Packaging FY26 PAT Up 20% to ₹72.87 Cr; Pharma Segment Grows 209%
Mold-Tek Packaging reported a strong FY26 with a 20.35% increase in Net Profit to ₹72.87 Cr and a 13.44% rise in revenue to ₹886.61 Cr. The Pharma Packaging segment was the standout performer, recording an exceptional volume growth of 208.96%, while the FMCG and Paint segments also saw healthy growth. The company successfully consolidated its Hyderabad operations from five units to two, which is expected to improve margins from FY27 onwards. Management has guided for a turnover exceeding ₹1,000 Cr in FY27, supported by new capacities for the Aditya Birla Group.
Key Highlights
FY26 Revenue grew 13.44% YoY to ₹886.61 Cr, with EBITDA per kg improving to ₹40.74.
Pharma segment volume surged 208.96% YoY, achieving the projected turnover of ₹35 Cr.
Q4 FY26 Net Profit rose 26.88% YoY to ₹20.64 Cr, driven by a 17.37% increase in sales volume.
Management guides for ₹1,000 Cr+ revenue in FY27, aided by the new Mahad plant for Grasim Industries.
Operational efficiency improved via consolidation of Hyderabad units from 5 to 2, with full benefits expected in FY27.
👀 What to Watch
Investors should focus on the high-margin Pharma segment's rapid growth and the upcoming ₹1,000 Cr revenue milestone as key re-rating triggers. The consolidation of units and new capacity for Grasim suggest strong earnings visibility and margin expansion potential for FY27.
Mold-Tek Packaging Declares First Interim Dividend of ₹2 Per Share for FY 2025-26
Mold-Tek Packaging Limited has announced its first interim dividend for the financial year 2025-26. The Board of Directors approved a payout of ₹2 per equity share, which translates to 40% of the face value of ₹5. The record date to determine shareholder eligibility has been set for April 24, 2026. This announcement demonstrates the company's consistent policy of rewarding shareholders through periodic payouts.
Key Highlights
First Interim Dividend of ₹2 per equity share declared for FY 2025-26
Dividend payout represents 40% of the face value of ₹5 per share
Record date for dividend eligibility is fixed as April 24, 2026
The dividend will be paid within the stipulated legal timelines
👀 What to Watch
Investors interested in the dividend should ensure they hold the shares before the ex-dividend date (typically one day prior to the record date). The payout reflects healthy cash flows and a shareholder-friendly management approach.
Mold-Tek Packaging Declares Interim Dividend of ₹2 Per Share for FY 2025-26
Mold-Tek Packaging Limited has declared its first interim dividend of ₹2 per equity share for the financial year 2025-26. This dividend represents a 40% payout on the face value of ₹5 per share. The company has established April 24, 2026, as the record date to identify eligible shareholders for this payment. The board meeting was conducted efficiently, concluding within 35 minutes on April 20, 2026.
Key Highlights
Interim dividend of ₹2 per equity share declared for FY 2025-26
Dividend payout represents 40% of the face value of ₹5 per share
Record date for eligibility fixed as Friday, April 24, 2026
Board meeting held on April 20, 2026, between 11:00 A.M. and 11:35 A.M.
👀 What to Watch
Investors interested in the dividend should ensure they hold the stock before the ex-dividend date to be eligible for the ₹2 per share payout. This announcement reflects the company's commitment to returning value to shareholders.
Mold-Tek Packaging Board to Consider Interim Dividend on April 20; Record Date April 24
Mold-Tek Packaging Limited has scheduled a board meeting on April 20, 2026, to consider and declare the first interim dividend for the financial year 2025-26. The company has proactively fixed April 24, 2026, as the record date to determine shareholder eligibility for the potential payout. This announcement comes while the trading window remains closed since April 1, 2026, in anticipation of the audited financial results for the year ended March 31, 2026. Investors should watch for the specific dividend amount to be disclosed following the board's decision.
Key Highlights
Board meeting scheduled for April 20, 2026, to deliberate on the first interim dividend for FY 2025-26.
Record date for dividend eligibility is fixed as Friday, April 24, 2026, contingent on board approval.
Trading window for designated persons has been closed since April 1, 2026, pending audited annual results.
The move signals management's intent to return capital to shareholders early in the new fiscal year.
👀 What to Watch
Investors seeking dividend income should monitor the April 20 announcement for the quantum of the dividend. To be eligible for the payout, shares must be held in the demat account by the record date of April 24, 2026.
Mold-Tek Packaging Q3 FY26: EBITDA Up 14%, Targets ₹1,000 Cr Revenue in FY27
Mold-Tek Packaging reported a 14% YoY EBITDA growth in Q3 FY26, despite the quarter being seasonally weak. The company is consolidating its Hyderabad operations from five units into two to enhance operational efficiency and cost control, with benefits expected from next quarter. Management has set an ambitious revenue target of over ₹1,000 crore for FY27, driven by a 12-15% volume growth outlook. The Pharma segment remains a key growth lever, with a target of ₹50-55 crore for the next fiscal year.
Key Highlights
9M FY26 EBITDA grew by 20% YoY, while Q3 volumes increased by 6%.
Revised FY26 volume guidance to 42,500 tons (11% growth) due to extended monsoons.
Pharma segment on track for ₹35 crore in FY26 with 25+ clients cleared for production.
Manufacturing consolidation in Hyderabad to be completed by March 2026 to improve margins.
Projected FY26 PAT of ₹73-75 crore, representing a 20% year-on-year growth.
👀 What to Watch
Investors should focus on the company's transition into high-margin Pharma packaging and the efficiency gains from plant consolidation. The ₹1,000 crore revenue guidance for FY27 suggests strong management confidence in volume recovery.
Mold-Tek Packaging 9M FY26 EBITDA Up 20% to ₹125.55 Cr; Pharma Volume Surges 190%
Mold-Tek Packaging reported a 12% YoY revenue growth to ₹648.75 crore for 9M FY26, while PAT rose 18% to ₹52.23 crore. The company demonstrated strong operational efficiency with EBITDA margins expanding to 19.35% and EBITDA per kg rising 10% to ₹40.24. The Pharma vertical is emerging as a high-growth driver, recording a 190% volume jump in Q3 FY26. Furthermore, a new MoU for UK-based high-precision closures offers a ₹250 crore revenue opportunity over five years.
Key Highlights
9M FY26 EBITDA grew 20% YoY to ₹125.55 crore with margins improving by 125 bps to 19.35%
Pharma segment Q3 volume grew 190% YoY, contributing ₹10.81 crore in quarterly sales
Strategic MoU with Vibe Generation Holdings (UK) targets ₹250 crore revenue over 5 years
9M FY26 Sales Volume reached 31,203 MT, a 9% increase over the previous year
EBITDA per KG increased from ₹36.73 to ₹40.24, indicating a shift towards high-value products
👀 What to Watch
Investors should view the margin expansion and rapid Pharma growth as strong indicators of successful business diversification. The stock remains a quality play on rigid packaging with significant upside potential from the new international partnership.
